elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39187610-0DF4A234-E98D-4E5F-A4DF-D38E178E92C8
Q39187610-0DF4A234-E98D-4E5F-A4DF-D38E178E92C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39187610-0DF4A234-E98D-4E5F-A4DF-D38E178E92C8
How to manage mantle cell lymphoma.
P2860
Q39187610-0DF4A234-E98D-4E5F-A4DF-D38E178E92C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39187610-0DF4A234-E98D-4E5F-A4DF-D38E178E92C8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fcb5c29da16c8ce3b2275c72bec3a5daba880b5d
P2860
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.